Skip to main content
. Author manuscript; available in PMC: 2007 Sep 17.
Published in final edited form as: Pharmacogenet Genomics. 2006 Dec;16(12):891–899. doi: 10.1097/01.fpc.0000236324.96056.16

Table 4.

E298D genotype by smoking interaction and risk of incident CHD and strokea,b

Caucasian African-American
Smoking exposure E298D genotype Interactionc E298D genotype Interactionc
CHDd G/G n = 365/279 G/T + T/T n = 416/335 G/G n = 182/241 G/T + T/T n = 44/70
Current smoker
 No   1 (referent)  0.83 (0.61−1.13)  2.10 (1.17−3.76)   1 (referent)  0.63 (0.34−1.16)  1.17 (0.43−3.18)
 Yes  1.19 (0.77−1.83)  2.07 (1.39−3.07) P=0.013  1.90 (1.17−3.10)  1.40 (0.62−3.18) P=0.762
Pack-years
 < 20 years   1 (referent)  0.84 (0.61−1.17)  1.50 (0.89−2.53)   1 (referent)  0.61 (0.35−1.06)  1.30 (0.43−3.90)
 ≥ 20 years  1.23 (0.83−1.83)  1.56 (1.08−2.24) P=0.126  1.19 (0.73−1.93)  0.94 (0.35−2.50) P=0.641
Strokee G/G n = 70/296 G/T + T/T n = 80/363 G/G n = 85/254 G/T + T/T n = 30/68
Current smoker
 No   1 (referent)  0.81 (0.51−1.30)  1.70 (0.71−4.06)   1 (referent)  1.26 (0.57−2.77)  1.24 (0.37−4.19)
 Yes  1.58 (0.83−3.00)  2.18 (1.19−3.99) P=0.234  2.00 (1.08−3.69)  3.12 (1.22−7.99) P=0.726
Pack-years
 < 20 years   1 (referent)  0.80 (0.46−1.38)  1.48 (0.66−3.31)   1 (referent)  1.36 (0.67−2.74)  1.00 (0.25−4.01)
 ≥ 20 years  1.49 (0.81−2.75)  1.77 (0.98−3.21) P=0.337  1.39 (0.70−2.75)  1.88 (0.53−6.62) P=0.999

CHD, coronary heart disease; HRR, hazard rate ratio; CI, confidence interval.

a

Number of cases/noncases in each genotype cell.

b

Data presented as HRR (95% CI).

c

Multiplicative E298D by smoking interaction term HRR (95% CI), and P-value.

d

Adjusted for age, sex, study center, diabetes, hypertension, HDL cholesterol, total cholesterol, and body mass index.

e

Adjusted for age, sex, study center, diabetes, and hypertension.